Viewing Study NCT02975206


Ignite Creation Date: 2025-12-26 @ 2:41 PM
Ignite Modification Date: 2026-03-02 @ 8:50 AM
Study NCT ID: NCT02975206
Status: COMPLETED
Last Update Posted: 2021-05-20
First Post: 2016-11-22
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
Sponsor: Vyne Therapeutics Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pruritus View
None Atopic Dermatitis View
Keywords: